Akoya Biosciences Newsroom

Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

Yahoo FinanceMay 5 10:00 ET

Quanterix Shareholder Issues Statement on Akoya Biosciences Merger Pact

TipRanksApr 30 09:03 ET

Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders

Business WireApr 30 08:00 ET

CCORF Maintains Akoya Biosciences(AKYA.US) With Hold Rating, Cuts Target Price to $1.8

Moomoo NewsApr 29 14:31 ET · Ratings

Akoya Biosciences Is Maintained at Hold by Canaccord Genuity

Dow JonesApr 29 08:44 ET · Ratings

Akoya Biosciences Price Target Cut to $1.80/Share From $3.50 by Canaccord Genuity

Dow JonesApr 29 08:44 ET · Ratings

Quanterix: In Light of Recent Volatility, We Re-Engaged With Akoya to Revise the Terms of the Agreemen >QTRX

Dow JonesApr 29 07:06 ET

Quanterix Will Issue Over 9 M Fewer Shrs Than Under the Original Deal Terms >QTRX

Dow JonesApr 29 07:06 ET

Express News | Quanterix Corp - Akoya Shareholders to Receive $0.38 Cash and 0.1461 Quanterix Shares

ReutersApr 29 07:00 ET

Express News | Quanterix and Akoya Biosciences Announce Amended Merger Agreement

ReutersApr 29 07:00 ET

Press Release: Quanterix and Akoya Biosciences Announce Amended Merger Agreement

Dow JonesApr 29 07:00 ET

Akoya Biosciences | 10-K/A: Annual report (Amendment)

SECApr 28 06:04 ET · Announcements

Express News | Akoya Biosciences And Enable Medicine Collaborate To Deliver Single-Cell Spatial Proteomics Atlas

BenzingaApr 24 08:02 ET

Express News | Akoya Biosciences Expands Portfolio With ADC Breast Cancer Assay And Real-world IO60 Insights At AACR 2025

BenzingaApr 24 08:01 ET

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

GlobeNewswireApr 24 08:00 ET

Akoya Biosciences Expands Biopharma Service Portfolio With New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

GlobeNewswireApr 24 08:00 ET

Akoya Biosciences Collaborates With Singapore Translational Cancer Consortium on SUPER Study to Enhance Immunotherapy Response Analysis

Quiver QuantitativeApr 23 08:13 ET

Express News | Akoya Biosciences and Singapore Translational Cancer Consortium (Stcc) Partner on Super Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

ReutersApr 23 08:00 ET

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

GlobeNewswireApr 23 08:00 ET

Kent Lake, A 7.7% Shareholder Of Quanterix Announces It Has Filed A Definitive Proxy Statement With The U.S. SEC And Sent Letter To Quanterix Shareholders In Connection With Its Opposition To The Company's Proposed Merger With Akoya Biosciences

BenzingaApr 17 08:38 ET